Prospective validation study for evaluation of tumor cell content rate in stereomicroscopic on-site evaluation of the EUS-guided tissue acquistion for unresectable pancreatic cancer

Prospective validation study for evaluation of tumor cell content rate in stereomicroscopic on-site evaluation of the EUS-guided tissue acquistion for unresectable pancreatic cancer - Prospective validation study for evaluation of tumor cell content rate in stereomicroscopic on-site evaluation of the EUS-guided tissue acquistion for unresectable pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044085

Enrollment

Registered

2021-07-01

Start date

2021-07-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable pancreatic cancer

Interventions

procedure of the EUS-TA with SOSE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pancreatic cancer which are required EUS-TA for pathological diagnosis 2) Patients whom suspected unresectable pancreatic cancer 3) Adequate organ functions 4) Providing written informed consent, and age over 20

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Rate of histopathological specimens with tumor cell content rate greater than 20%.	—

Countries

Japan

Contacts

Public ContactMasafumi Watanabe

Kitasato University School of Medicine Department of Gastroenterology

m.wata@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026